Why ArriVent BioPharma (AVBP) Stock Fell 3.25% in 10 Minutes on Oct 6, 2026
264,061 shares changed hands in those 10 minutes.
- AVBP fell 3.25% in the 10 minutes after the 08:52:00 ET headline, from $11.99 to $11.60.
- The headline crossed in pre-market trading, 38 minutes before the 9:30 ET open.
- The first minute was nearly flat at +0.08%; the stock reached -3.25% at 10 minutes.
08:52:00 ET
Reaction by asset (real prices)
| Asset | 2m before | At release | +1m | +10m | +1m % | +10m % |
|---|---|---|---|---|---|---|
| AVBP | 11.99 | 11.99 | 12.00 | 11.60 | +0.08% | -3.25% |
ArriVent BioPharma (AVBP) shares fell 3.25% in the 10 minutes after this headline reached the MoveSurge news feed at 08:52:00 ET on Tuesday, October 6, 2026: “ArriVent BioPharma's lung cancer treatment did not achieve its primary goal in a Phase 3 trial.”
AVBP in the first 10 minutes
From a reference price of $11.99 just before the headline, the stock was up 0.08% after one minute and down 3.25%, at $11.60, after 10 minutes. The first minute was nearly flat; the move came after it. 264,061 shares changed hands in those 10 minutes. The headline crossed in pre-market trading, 38 minutes before the 9:30 ET open.
ArriVent BioPharma at a glance
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Market value | $833 million (as of Oct 8, 2026) |
Prices are closes of 1-minute bars. Each move on this page is measured from the last completed bar before its headline.
What headline moved ArriVent BioPharma stock on October 6, 2026?
At 08:52:00 ET, this headline crossed: “ArriVent BioPharma's lung cancer treatment did not achieve its primary goal in a Phase 3 trial.” The stock fell 3.25% in the next 10 minutes.
How far did AVBP move after the headline?
From $11.99 just before the headline to $11.60 10 minutes later, a -3.25% move.
Sources
-
AVBP headline and measured reaction, Oct 6, 2026
— MoveSurge
The headline as it crossed, its timestamp, and the measured price reaction reported on this page.
Never miss the next market-moving story
Follow the core market-moving feed across equities, macro, currencies and commodities. Your subscription includes recorded price reactions, search, watchlists, alerts and research tools.
Create free accountGo real time Watch live headlines -- free